ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
ANG Lifesciences India Ltd · Outcome · 15 Nov 2026, 2:53 am
ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 2,010 (-22.9% YoY | +31.4% QoQ) ■ EBITDA: -26.4 (Profit to Loss YoY | +86.5% QoQ) ■ EBITDA Margin (%): -1.3 (Profit to Loss YoY | +1145 bps QoQ) ■ PAT: -209 (+29.1% YoY | +50.8% QoQ) ■ EPS (INR): -1.59 (+29.0% YoY | +50.9% QoQ) ANG Lifesciences India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Pharmaceuticals ■ Revenue: 1,858 (-28.5% YoY | +33.1% QoQ) ■ EBIT: -171 (Profit to Loss YoY | +37.6% QoQ) ■ EBIT Margin (%): -9.2 (Profit to Loss YoY | +1043 bps QoQ) Printing and packagings ■ Revenue: 210 (+85.8% YoY | -0.9% QoQ) ■ EBIT: 17.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 8.2 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from ANG Lifesciences India Ltd
- Cessation of Independent Director upon completion of tenure. · 18 Nov 2026
- Appointment of Mrs. Preeti Sarin as Additional Independent Director of the Company · 15 Nov 2026
- Financial Results for the quarter and half year ended 30.09.2026. · 15 Nov 2026
- ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial .... · 14 Nov 2026
- Scrutinizer''s Report for AGM along with Voting Results · 01 Oct 2026
- Re-appointment of Ms. Chetna as the Independent Director of the company. · 30 Sept 2026
- Proceedings of 20th Annual General Meeting are enclosed herewith. · 30 Sept 2026
- Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended ('''' Listing Regulations''''), please find attached herewith the Annual Report of the Company for the .... · 08 Sept 2026
